Takeda Pharmaceutical (NYSE: TAK)
You’re reading a free stock page from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More
Takeda Pharmaceutical Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Takeda Pharmaceutical Company Info
Takeda Pharmaceutical Co., Ltd. engages in the research and development, manufacture, import and export sale, and marketing of pharmaceutical drugs. It operates through the following segments: Prescription Drug, Consumer Healthcare, and Other. The Prescription Drugs segment includes the manufacture and sale of pharmaceutical products. The Consumer Healthcare segment includes the manufacture and sale of OTC drugs and quasi-drugs. The Other segment includes manufacture and sale of reagents, clinical diagnostics, and chemical products. The company was founded by Takeda Chobei on June 12, 1781 and is headquartered in Osaka, Japan.
News & Analysis
One of these high-yield pharma stocks stands out as a better buy right now.
These two high-yield dividend stocks are attractive buys right now.
Is now the time to load up on these high-yielding investments?
These stocks all pay far higher than the S&P 500 average dividend yield of 1.8%.
These stocks both yield more than three times the S&P 500 average.
Improving your investing process tends to have high returns.
These three healthcare stocks should hold their value for years.
These two dividend-paying pharma stocks ought to be top performers in 2022.
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.